कृपया अन्य खोज का प्रयास करें
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; ICOone single-dose disposable dry powder inhaler; and ICOone nasal single-dose dry powder inhaler now for nasal use. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius to develop dry powder inhalation product, as well as collaboration with Monash h University to. to develop an inhalable and preventive oxytocin treatment to provide effective protection against cotries. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Mats Johansson | 61 | 2013 | Director |
Berndt Axelsson | 63 | 2013 | Independent Director |
Rikard Roos | 49 | - | Member of Business Advisory Board |
Sven Totté | 53 | 2017 | Independent Director |
Gunnar Gardemyr | 63 | 2020 | Independent Chairman of the Board |
Lennart Holm | 63 | - | Member of Business Advisory Board |
Kjell Larsson | - | - | Member of Scientific Advisory Board |
Björn Andersson | - | - | Member of Business Advisory Board |
Orest Lastow | 59 | 2013 | Co-Founder, CTO, Innovation Lead & Director |
Carl Lindgren | 55 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है